Advanced Research Projects Agency for Health logo
Advanced Research Projects Agency for Health

One Comprehensive Universal Radiotherapy for Everyone (1-CURE)

Funds research teams developing a single low-cost radiotherapy treatment for all cancers.

ClosedAdvanced Research Projects Agency for HealthUnited States

ARPA-H runs this as a solicitation posted on SAM.gov under Notice ID ARPA-H-SOL-26-147: proposers first submit a solution summary, and only those encouraged to continue are expected to submit a full proposal. Program Manager Wilfred Ngwa leads it, and ARPA-H expects proposers to form teams before applying, offering a teaming page and an optional Proposers' Day to help them connect. Funding flows tโ€ฆ

ARPA-H wants interdisciplinary teams to build one radiotherapy approach effective against local, metastatic and treatment-resistant cancers. The program covers two technical areas: smart radiotherapy biomaterials that deliver image-guided, sustained immune-boosting therapy, and an AI-driven treatment planning system that combines those biomaterials with FLASH radiotherapy. Teams should bring expertise across physics, immunology, materials science, AI, engineering, clinical oncology and advanced manufacturing.

CycleiHow often this grant runs - e.g. annually, on a rolling basis, or a one-off call.No fixed schedule
Next deadlineiThe next date applications are due. Rolling means you can apply any time.-
Decision timeiTypical time from the deadline to the funder's decision.-
Project durationiHow long the funded work is expected to run.-
Award typeiThe form of funding - grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.-
Funding pooliThe total budget available across all awards in this round.-

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see the timeline

Sign up free to see where teams trip up

Guides for this application

All guides โ†’
National Center for Advancing Translational Sciences logo
Open

NCATS Preclinical Proof of Concept Studies for Rare Diseases

๐Ÿ‡บ๐Ÿ‡ธNCATS ยท United States

Funds U.S. researchers and companies conducting preclinical efficacy studies to advance therapeutic candidates for rare diseases toward IND applications.

BiotechMedtech+1
$275KJun'27
Office of the Governor โ€” Economic Development & Tourism logo
Open

Governor's University Research Initiative

๐Ÿ‡บ๐Ÿ‡ธTexas EDT ยท United States

Funds Texas public universities to recruit nationally recognized scientific leaders and strengthen talent pipelines.

BiotechMedtech+3
$5M
National Center for Advancing Translational Sciences logo
Open

NCATS Clinical Trial Readiness for Rare Diseases

๐Ÿ‡บ๐Ÿ‡ธNCATS ยท United States

Funds U.S. researchers and companies generating natural history data, biomarkers, and outcome measures needed to design clinical trials for rare diseases.

BiotechMedtech+1
$275KFeb'27
National Institutes of Health logo
Open

NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)

๐Ÿ‡บ๐Ÿ‡ธNIH ยท United States

Funds an investigator's own phase I trial in heart, lung, blood or sleep disease โ€” with every regulatory approval already in hand at award.

BiotechMedtech
$1.5MJan'27
National Institutes of Health logo
Open

BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS

๐Ÿ‡บ๐Ÿ‡ธNIH ยท United States

Funds a novel recording or modulation technology for the human central nervous system from proof of concept up to readiness for first-in-human studies.

NeurotechMedtech+1
$750KJan'27
National Institutes of Health logo
Open

Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy

๐Ÿ‡บ๐Ÿ‡ธNIH ยท United States

Funds work combining imaging with liquid biopsy during cancer treatment, to see sooner whether it is working or resistance is emerging.

MedtechBiotech
$500KJan'28